Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1
Open Access
- 1 February 2000
- Vol. 55 (2) , 121-125
- https://doi.org/10.1136/thorax.55.2.121
Abstract
BACKGROUND Although smoking is the major causal factor in the development of chronic obstructive pulmonary disease (COPD), only 10–20% of chronic heavy cigarette smokers develop symptomatic COPD which suggests the presence of genetic susceptibility. This genetic susceptibility to COPD might depend on variations in enzyme activities that detoxify cigarette smoke products such as microsomal epoxide hydrolase (mEPHX) and glutathione-S transferase (GST). As there is increasing evidence that several genes influence the development of COPD, multiple gene polymorphisms should be investigated to find out the genetic susceptibility to COPD. METHODS The genotypes of 83 patients with COPD and 76 healthy smoking control subjects were determined by polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (PCR-RFLP) for the mEPHX gene, and multiplex PCR for GST M1 and GST T1 genes. The frequencies of polymorphic genotypes of mEPHX, GST M1, and GST T1 genes were compared both individually and in combination in patients with COPD and healthy smokers. RESULTS No differences were observed in the frequency of polymorphic genotypes in exons 3 and 4 of mEPHX, GST M1, and GST T1 genes between patients with COPD and healthy smokers. The frequencies of any combination of these genotypes also showed no differences between the COPD group and the control group. CONCLUSIONS Genetic polymorphisms in mEPHX, GST M1, and GST T1 genes are not associated with the development of COPD in Koreans.Keywords
This publication has 24 references indexed in Scilit:
- Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysemaThe Lancet, 1997
- Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defectThe Lancet, 1996
- Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onsetCarcinogenesis: Integrative Cancer Research, 1995
- Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase thetaCarcinogenesis: Integrative Cancer Research, 1995
- Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung.Thorax, 1994
- Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder CancerJNCI Journal of the National Cancer Institute, 1993
- The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lungCarcinogenesis: Integrative Cancer Research, 1993
- The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomasCarcinogenesis: Integrative Cancer Research, 1993
- Differential susceptibility to tobacco smoke: possible mechanismsPharmacogenetics, 1991
- Neonatal screening for alpha1-antitrypsin deficiencyThe Journal of Pediatrics, 1978